|
Home : Unsafe Drugs : Avandia : Newsfeeds : Avandia raises heart risk but should stay on market, FDA panel finds Avandia raises heart risk but should stay on market, FDA panel finds
WEDNESDAY, July 14 (HealthDay News) -- The controversial diabetes drug Avandia does raise the risk of heart attack more than other medications of its kind but should stay on the market with tightened controls, a U.S. government advisory panel recommended ...
Avandia Case Evaluation Form
This form is secure and encrypted. More information about secure forms and your privacy here.
|




